Page last updated: 2024-10-23

aztreonam and Meningitis, Meningococcal, Serogroup A

aztreonam has been researched along with Meningitis, Meningococcal, Serogroup A in 2 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Isani, Z1
Rehman, N1
Adil, N1
el Messidi, M1
Greenman, RL1
Arcey, SM1
Dickinson, GM1
Mokhbat, JE1
Sabath, LD1
Platt, TB1
Friedhoff, LT1

Other Studies

2 other studies available for aztreonam and Meningitis, Meningococcal, Serogroup A

ArticleYear
Aztreonam in the treatment of gram-negative meningitis in children.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Anti-Bacterial Agents; Aztreonam; Child, Preschool; Escherichia coli Infections; Gram-Negative Bacte

1987
Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 15, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Female; Humans; Male; Meningitis; Meningitis, Meningo

1985